ALTAMIRA THERAPEUTICS LTD (CYTOF)
CYTOF moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How CYTOF actually reacts to news — the realized, point-in-time move the market made, measured across 29 labeled events over the last three years with zero look-ahead.
CYTOF’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 8% | 24 |
| 30-min | 0.00% | 13% | 24 |
| 60-min | 0.00% | 21% | 24 |
| to close | 0.00% | 44% | 25 |
Small sample: only 29 measured events — treat these medians as indicative, not stable.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when CYTOF moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to CYTOF's baseline. Nothing else.
Recent CYTOF events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Altamira Therapeutics Announces Publication Highlighting Potential of RNA Nanoparticles for Disease-Modifying Treatment of Osteoarthritis | Press release | ACCESS Newswire | -0.20% | -0.20% | |
| Altamira Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results | Press release | ACCESS Newswire | -0.69% | -0.69% | |
| Altamira Therapeutics Announces Release Date for 2025 Annual Report and Financial Statements | Press release | ACCESS Newswire | — | — | |
| Form 15-12G Altamira Therapeutics | SEC filing · Form 15-12G | SEC EDGAR | +0.00% | -20.00% | |
| Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Bentrio Nasal Spray | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit | Press release | ACCESS Newswire | — | — | |
| Altamira Therapeutics Announces Market Approval of Bentrio Nasal Spray in China | Press release | ACCESS Newswire | +0.00% | -25.00% | |
| Altamira Therapeutics Announces Certification of Bentrio Nasal Spray under Medical Device Regulation | Press release | ACCESS Newswire | -22.22% | -21.11% | |
| Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules | Press release | ACCESS Newswire | +0.00% | -39.13% | |
| Altamira Therapeutics Provides Business Update and First Half 2025 Financial Results | Press release | ACCESS Newswire | -5.46% | -6.73% | |
| Form 6-K Altamira Therapeutics For: Jun 30 | SEC filing · Form 6-K | SEC EDGAR | -5.46% | -6.73% | |
| Altamira Therapeutics to Host First Half 2025 Financial Results and Business Update Call on August 29, 2025 | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Intranasal Betahistine | Press release | ACCESS Newswire | +0.00% | -19.92% | |
| Form 6-K Altamira Therapeutics For: Jun 11 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +13.96% | |
| Altamira Therapeutics Announces Collaboration on Circular RNA Delivery | Press release | GlobeNewswire | +42.86% | +27.29% | |
| Form 6-K Altamira Therapeutics For: May 09 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +24.34% | |
| Altamira Therapeutics Provides Business Update, Reports Full Year 2024 Financial Results | Press release | GlobeNewswire | +0.00% | +12.36% | |
| Form 20-F Altamira Therapeutics For: Dec 31 | SEC filing · Form 20-F | SEC EDGAR | — | +12.50% | |
| Form 6-K Altamira Therapeutics For: Apr 30 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +12.36% | |
| Altamira Therapeutics to Host Full Year 2024 Financial Results and Business Update Call on April 30, 2025 | Press release | GlobeNewswire | +0.00% | -9.18% | |
| Form S-8 Altamira Therapeutics | SEC filing · Form S-8 | SEC EDGAR | -28.53% | -28.53% | |
| Form 6-K Altamira Therapeutics For: Mar 10 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +9.12% | |
| Altamira Announces Notice of Allowance from USPTO for Bentrio Nasal Spray Patent | Press release | GlobeNewswire | +0.00% | -36.81% | |
| Altamira Therapeutics Announces Collaboration on Radiopharmaceutical Targeting Strategies | Press release | GlobeNewswire | +0.00% | +27.27% | |
| Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA | Press release | GlobeNewswire | +21.43% | +57.86% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the CYTOF section they belong to.
Where else CYTOF is measured.
CYTOF earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is ALTAMIRA THERAPEUTICS LTD's median reaction calculated?
Every labeled CYTOF news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 29 events is what this page reports. On a sample this small (29 events), treat these medians as indicative, not stable. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does CYTOF's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.